Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soulsby

Showing results (261-270 of 278) with videos related to

Pageof 28
Sort By:
Biological Psychiatry|July 20, 2005
Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosisBelinda Garner, Carmine M Pariante, Stephen J Wood, et al.
BMJ Open|November 17, 2025
Multicancer early detection in a cohort of patients with confirmed and suspected cancer by measuring plasma amino acid cross sections with the Enlighten test: MODERNISED protocolSam Wilding, Victoria Goss, Wesley Sukdao, et al.
BMJ Open|August 27, 2021
Spironolactone for adult female acne (SAFA): protocol for a double-blind, placebo-controlled, phase III randomised study of spironolactone as systemic therapy for acne in adult womenSusanne Renz, Fay Chinnery, Beth Stuart, et al.
BMJ Open|December 11, 2023
Cost-effectiveness of Spironolactone for Adult Female Acne (SAFA): economic evaluation alongside a randomised controlled trialSarah Pyne, Tracey H Sach, Megan Lawrence, et al.
BMC Pediatrics|April 9, 2025
Study protocol for assessing the effectiveness, implementation fidelity and uptake of attachment & child health (ATTACH™) Online: helping children vulnerable to early adversityNicole Letourneau, Lubna Anis, Cui Cui, et al.
Health Technology Assessment (Winchester, England)|September 13, 2024
Clinical and cost-effectiveness of spironolactone in treating persistent facial acne in women: SAFA double-blinded RCTMiriam Santer, Megan Lawrence, Sarah Pyne, et al.
BMJ (Clinical Research Ed.)|May 16, 2023
Effectiveness of spironolactone for women with acne vulgaris (SAFA) in England and Wales: pragmatic, multicentre, phase 3, double blind, randomised controlled trialMiriam Santer, Megan Lawrence, Susanne Renz, et al.
Trials|August 27, 2025
Social media recruitment enhances participant diversity in dermatology clinical trial: findings from the SAFA trialCherish Boxall, Susanne Renz, Beth Stuart, et al.
The International Journal of Behavioral Nutrition and Physical Activity|May 31, 2023
Exploring views of members of the public and policymakers on the acceptability of population level dietary and active-travel policies: a qualitative studyZ Toumpakari, S Valerino-Perea, K Willis, et al.
Trials|October 17, 2019
What are the most important unanswered research questions in trial retention? A James Lind Alliance Priority Setting Partnership: the PRioRiTy II (Prioritising Retention in Randomised Trials) studyDan Brunsdon, Linda Biesty, Peter Brocklehurst, et al.
Pageof 28

Showing results (261-270 of 278) with videos related to

Sort By:
Pageof 28
Biological Psychiatry|July 20, 2005
Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosisBelinda Garner, Carmine M Pariante, Stephen J Wood, et al.
BMJ Open|November 17, 2025
Multicancer early detection in a cohort of patients with confirmed and suspected cancer by measuring plasma amino acid cross sections with the Enlighten test: MODERNISED protocolSam Wilding, Victoria Goss, Wesley Sukdao, et al.
BMJ Open|August 27, 2021
Spironolactone for adult female acne (SAFA): protocol for a double-blind, placebo-controlled, phase III randomised study of spironolactone as systemic therapy for acne in adult womenSusanne Renz, Fay Chinnery, Beth Stuart, et al.
BMJ Open|December 11, 2023
Cost-effectiveness of Spironolactone for Adult Female Acne (SAFA): economic evaluation alongside a randomised controlled trialSarah Pyne, Tracey H Sach, Megan Lawrence, et al.
BMC Pediatrics|April 9, 2025
Study protocol for assessing the effectiveness, implementation fidelity and uptake of attachment & child health (ATTACH™) Online: helping children vulnerable to early adversityNicole Letourneau, Lubna Anis, Cui Cui, et al.
Health Technology Assessment (Winchester, England)|September 13, 2024
Clinical and cost-effectiveness of spironolactone in treating persistent facial acne in women: SAFA double-blinded RCTMiriam Santer, Megan Lawrence, Sarah Pyne, et al.
BMJ (Clinical Research Ed.)|May 16, 2023
Effectiveness of spironolactone for women with acne vulgaris (SAFA) in England and Wales: pragmatic, multicentre, phase 3, double blind, randomised controlled trialMiriam Santer, Megan Lawrence, Susanne Renz, et al.
Trials|August 27, 2025
Social media recruitment enhances participant diversity in dermatology clinical trial: findings from the SAFA trialCherish Boxall, Susanne Renz, Beth Stuart, et al.
The International Journal of Behavioral Nutrition and Physical Activity|May 31, 2023
Exploring views of members of the public and policymakers on the acceptability of population level dietary and active-travel policies: a qualitative studyZ Toumpakari, S Valerino-Perea, K Willis, et al.
Trials|October 17, 2019
What are the most important unanswered research questions in trial retention? A James Lind Alliance Priority Setting Partnership: the PRioRiTy II (Prioritising Retention in Randomised Trials) studyDan Brunsdon, Linda Biesty, Peter Brocklehurst, et al.
Pageof 28